Human mitochondrial RNA polymerase: Structure-function, mechanism and inhibition

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1819, Issue 9-10, 2012, Pages 948-960

  Arnold, Jamie J ^a   Smidansky, Eric D ^a   Moustafa, Ibrahim M ^a   Cameron, Craig E ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Mitochondrial RNA polymerase; Mitochondrion; MtRNAP; POLRMT; Transcription

Indexed keywords

NUCLEOTIDYLTRANSFERASE; RNA POLYMERASE;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; ENZYME INHIBITION; ENZYME KINETICS; GENE IDENTIFICATION; HUMAN; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

DNA, MITOCHONDRIAL; DNA-DIRECTED RNA POLYMERASES; GENE EXPRESSION REGULATION; HUMANS; MITOCHONDRIA; PROTEIN BIOSYNTHESIS; PROTEIN CONFORMATION; RNA, RIBOSOMAL; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION, GENETIC;

EID: 84864306114     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2012.04.002     Document Type: Review

References (114)

1. Scheffler I.E. Mitochondria 1999, Wiley, New York.
2. McBride H.M., Neuspiel M., Wasiak S. Mitochondria: more than just a powerhouse. Curr. Biol. 2006, 16:R551-R560.
3. Scheffler I.E. Mitochondria make a come back. Adv. Drug Deliv. Rev. 2001, 49:3-26.
4. Scott I. The role of mitochondria in the mammalian antiviral defense system. Mitochondrion 2010, 10:316-320.
5. Brandon M., Baldi P., Wallace D.C. Mitochondrial mutations in cancer. Oncogene 2006, 25:4647-4662.
6. Coskun P., Wyrembak J., Schriner S., Chen H.W., Marciniack C., Laferla F., Wallace D.C. A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim. Biophys. Acta 2011.
7. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 2005, 39:359-407.
8. Wallace D.C. Mitochondrial DNA mutations in disease and aging. Environ. Mol. Mutagen. 2010, 51:440-450.
9. Wallace D.C., Fan W. Energetics, epigenetics, mitochondrial genetics. Mitochondrion 2010, 10:12-31.
10. Wallace D.C., Fan W., Procaccio V. Mitochondrial energetics and therapeutics. Annu. Rev. Pathol. 2010, 5:297-348.
11. Copeland W.C. Inherited mitochondrial diseases of DNA replication. Annu. Rev. Med. 2008, 59:131-146.
12. Larsson N.G., Clayton D.A. Molecular genetic aspects of human mitochondrial disorders. Annu. Rev. Genet. 1995, 29:151-178.
13. Falkenberg M., Larsson N.G., Gustafsson C.M. DNA replication and transcription in mammalian mitochondria. Annu. Rev. Biochem. 2007, 76:679-699.
14. Scarpulla R.C. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev. 2008, 88:611-638.
15. Shutt T.E., Bestwick M., Shadel G.S. The core human mitochondrial transcription initiation complex: it only takes two to tango. Transcription 2011, 2:55-59.
16. Fisher R.P., Lisowsky T., Parisi M.A., Clayton D.A. DNA wrapping and bending by a mitochondrial high mobility group-like transcriptional activator protein. J. Biol. Chem. 1992, 267:3358-3367.
17. Parisi M.A., Clayton D.A. Similarity of human mitochondrial transcription factor 1 to high mobility group proteins. Science 1991, 252:965-969.
18. Thomas J.O., Travers A.A. HMG1 and 2, and related 'architectural' DNA-binding proteins. Trends Biochem. Sci. 2001, 26:167-174.
19. Dairaghi D.J., Shadel G.S., Clayton D.A. Human mitochondrial transcription factor A and promoter spacing integrity are required for transcription initiation. Biochim. Biophys. Acta 1995, 1271:127-134.
20. Ekstrand M.I., Falkenberg M., Rantanen A., Park C.B., Gaspari M., Hultenby K., Rustin P., Gustafsson C.M., Larsson N.G. Mitochondrial transcription factor A regulates mtDNA copy number in mammals. Hum. Mol. Genet. 2004, 13:935-944.
21. Kaufman B.A., Durisic N., Mativetsky J.M., Costantino S., Hancock M.A., Grutter P., Shoubridge E.A. The mitochondrial transcription factor TFAM coordinates the assembly of multiple DNA molecules into nucleoid-like structures. Mol. Biol. Cell 2007, 18:3225-3236.
22. Larsson N.G., Wang J., Wilhelmsson H., Oldfors A., Rustin P., Lewandoski M., Barsh G.S., Clayton D.A. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat. Genet. 1998, 18:231-236.
23. Ngo H.B., Kaiser J.T., Chan D.C. The mitochondrial transcription and packaging factor Tfam imposes a U-turn on mitochondrial DNA. Nat. Struct. Mol. Biol. 2011, 18:1290-1296.
24. Rubio-Cosials A., Sidow J.F., Jimenez-Menendez N., Fernandez-Millan P., Montoya J., Jacobs H.T., Coll M., Bernado P., Sola M. Human mitochondrial transcription factor A induces a U-turn structure in the light strand promoter. Nat. Struct. Mol. Biol. 2011, 18:1281-1289.
25. Falkenberg M., Gaspari M., Rantanen A., Trifunovic A., Larsson N.G., Gustafsson C.M. Mitochondrial transcription factors B1 and B2 activate transcription of human mtDNA. Nat. Genet. 2002, 31:289-294.
26. Lodeiro M.F., Uchida A.U., Arnold J.J., Reynolds S.L., Moustafa I.M., Cameron C.E. Identification of multiple rate-limiting steps during the human mitochondrial transcription cycle in vitro. J. Biol. Chem. 2010, 285:16387-16402.
27. Shutt T.E., Lodeiro M.F., Cotney J., Cameron C.E., Shadel G.S. Core human mitochondrial transcription apparatus is a regulated two-component system in vitro. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:12133-12138.
28. Sologub M., Litonin D., Anikin M., Mustaev A., Temiakov D. TFB2 is a transient component of the catalytic site of the human mitochondrial RNA polymerase. Cell 2009, 139:934-944.
29. Cermakian N., Ikeda T.M., Miramontes P., Lang B.F., Gray M.W., Cedergren R. On the evolution of the single-subunit RNA polymerases. J. Mol. Evol. 1997, 45:671-681.
30. Greenleaf A.L., Kelly J.L., Lehman I.R. Yeast RPO41 gene product is required for transcription and maintenance of the mitochondrial genome. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:3391-3394.
31. Masters B.S., Stohl L.L., Clayton D.A. Yeast mitochondrial RNA polymerase is homologous to those encoded by bacteriophages T3 and T7. Cell 1987, 51:89-99.
32. Cermakian N., Ikeda T.M., Cedergren R., Gray M.W. Sequences homologous to yeast mitochondrial and bacteriophage T3 and T7 RNA polymerases are widespread throughout the eukaryotic lineage. Nucleic Acids Res. 1996, 24:648-654.
33. Tiranti V., Savoia A., Forti F., D'Apolito M.F., Centra M., Rocchi M., Zeviani M. Identification of the gene encoding the human mitochondrial RNA polymerase (h-mtRPOL) by cyberscreening of the Expressed Sequence Tags database. Hum. Mol. Genet. 1997, 6:615-625.
34. Shutt T.E., Gray M.W. Bacteriophage origins of mitochondrial replication and transcription proteins. Trends Genet. 2006, 22:90-95.
35. Ringel R., Sologub M., Morozov Y.I., Litonin D., Cramer P., Temiakov D. Structure of human mitochondrial RNA polymerase. Nature 2011, 478:269-273.
36. Joyce C.M., Steitz T.A. Function and structure relationships in DNA polymerases. Annu. Rev. Biochem. 1994, 63:777-822.
37. Smidansky E.D., Arnold J.J., Reynolds S., Cameron C.E. Biochemical characterization of human mitochondrial RNA polymerase reveals differences in formation and fidelity of elongation complexes relative to T7 RNA polymerase. Mitochondrion 2010, 10:214.
38. Anand V.S., Patel S.S. Transient state kinetics of transcription elongation by T7 RNA polymerase. J. Biol. Chem. 2006, 281:35677-35685.
39. Cheetham G.M., Steitz T.A. Structure of a transcribing T7 RNA polymerase initiation complex. Science 1999, 286:2305-2309.
40. Sousa R. T 7 RNA polymerase. Uirusu 2001, 51:81-94.
41. Guo Q., Nayak D., Brieba L.G., Sousa R. Major conformational changes during T7RNAP transcription initiation coincide with, and are required for, promoter release. J. Mol. Biol. 2005, 353:256-270.
42. Guo Q., Sousa R. Translocation by T7 RNA polymerase: a sensitively poised Brownian ratchet. J. Mol. Biol. 2006, 358:241-254.
43. Minczuk M., He J., Duch A.M., Ettema T.J., Chlebowski A., Dzionek K., Nijtmans L.G., Huynen M.A., Holt I.J. TEFM (c17orf42) is necessary for transcription of human mtDNA. Nucleic Acids Res. 2011, 39:4284-4299.
44. Endoh M., Zhu W., Hasegawa J., Watanabe H., Kim D.K., Aida M., Inukai N., Narita T., Yamada T., Furuya A., Sato H., Yamaguchi Y., Mandal S.S., Reinberg D., Wada T., Handa H. Human Spt6 stimulates transcription elongation by RNA polymerase II in vitro. Mol. Cell. Biol. 2004, 24:3324-3336.
45. Johnson S.J., Close D., Robinson H., Vallet-Gely I., Dove S.L., Hill C.P. Crystal structure and RNA binding of the Tex protein from Pseudomonas aeruginosa. J. Mol. Biol. 2008, 377:1460-1473.
46. Yoh S.M., Cho H., Pickle L., Evans R.M., Jones K.A. The Spt6 SH2 domain binds Ser2-P RNAPII to direct Iws1-dependent mRNA splicing and export. Genes Dev. 2007, 21:160-174.
47. Doublie S., Ellenberger T. The mechanism of action of T7 DNA polymerase. Curr. Opin. Struct. Biol. 1998, 8:704-712.
48. Doublie S., Tabor S., Long A.M., Richardson C.C., Ellenberger T. Crystal structure of a bacteriophage T7 DNA replication complex at 2.2 A resolution. Nature 1998, 391:251-258.
49. Johnson S.J., Taylor J.S., Beese L.S. Processive DNA synthesis observed in a polymerase crystal suggests a mechanism for the prevention of frameshift mutations. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:3895-3900.
50. Kiefer J.R., Mao C., Braman J.C., Beese L.S. Visualizing DNA replication in a catalytically active Bacillus DNA polymerase crystal. Nature 1998, 391:304-307.
51. Li Y., Korolev S., Waksman G. Crystal structures of open and closed forms of binary and ternary complexes of the large fragment of Thermus aquaticus DNA polymerase I: structural basis for nucleotide incorporation. EMBO J. 1998, 17:7514-7525.
52. Temiakov D., Patlan V., Anikin M., McAllister W.T., Yokoyama S., Vassylyev D.G. Structural basis for substrate selection by t7 RNA polymerase. Cell 2004, 116:381-391.
53. Yin Y.W., Steitz T.A. Structural basis for the transition from initiation to elongation transcription in T7 RNA polymerase. Science 2002, 298:1387-1395.
54. Yin Y.W., Steitz T.A. The structural mechanism of translocation and helicase activity in T7 RNA polymerase. Cell 2004, 116:393-404.
55. Castro C., Smidansky E.D., Arnold J.J., Maksimchuk K.R., Moustafa I., Uchida A., Gotte M., Konigsberg W., Cameron C.E. Nucleic acid polymerases use a general acid for nucleotidyl transfer. Nat. Struct. Mol. Biol. 2009, 16:212-218.
56. Steitz T.A. Visualizing polynucleotide polymerase machines at work. EMBO J. 2006, 25:3458-3468.
57. Steitz T.A. The structural changes of T7 RNA polymerase from transcription initiation to elongation. Curr. Opin. Struct. Biol. 2009, 19:683-690.
58. Cheetham G.M., Jeruzalmi D., Steitz T.A. Structural basis for initiation of transcription from an RNA polymerase-promoter complex. Nature 1999, 399:80-83.
59. Matsunaga M., Jaehning J.A. Intrinsic promoter recognition by a "core" RNA polymerase. J. Biol. Chem. 2004, 279:44239-44242.
60. Nayak D., Guo Q., Sousa R. A promoter recognition mechanism common to yeast mitochondrial and phage t7 RNA polymerases. J. Biol. Chem. 2009, 284:13641-13647.
61. Gaspari M., Falkenberg M., Larsson N.G., Gustafsson C.M. The mitochondrial RNA polymerase contributes critically to promoter specificity in mammalian cells. EMBO J. 2004, 23:4606-4614.
62. Brieba L.G., Sousa R. The T7 RNA polymerase intercalating hairpin is important for promoter opening during initiation but not for RNA displacement or transcription bubble stability during elongation. Biochemistry 2001, 40:3882-3890.
63. Stano N.M., Patel S.S. The intercalating beta-hairpin of T7 RNA polymerase plays a role in promoter DNA melting and in stabilizing the melted DNA for efficient RNA synthesis. J. Mol. Biol. 2002, 315:1009-1025.
64. Fuste J.M., Wanrooij S., Jemt E., Granycome C.E., Cluett T.J., Shi Y., Atanassova N., Holt I.J., Gustafsson C.M., Falkenberg M. Mitochondrial RNA polymerase is needed for activation of the origin of light-strand DNA replication. Mol. Cell 2010, 37:67-78.
65. Paratkar S., Deshpande A.P., Tang G.Q., Patel S.S. The N-terminal domain of the yeast mitochondrial RNA polymerase regulates multiple steps of transcription. J. Biol. Chem. 2011, 286:16109-16120.
66. Wang Y., Shadel G.S. Stability of the mitochondrial genome requires an amino-terminal domain of yeast mitochondrial RNA polymerase. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:8046-8051.
67. Rodeheffer M.S., Boone B.E., Bryan A.C., Shadel G.S. Nam1p, a protein involved in RNA processing and translation, is coupled to transcription through an interaction with yeast mitochondrial RNA polymerase. J. Biol. Chem. 2001, 276:8616-8622.
68. Rodeheffer M.S., Shadel G.S. Multiple interactions involving the amino-terminal domain of yeast mtRNA polymerase determine the efficiency of mitochondrial protein synthesis. J. Biol. Chem. 2003, 278:18695-18701.
69. Shadel G.S. Coupling the mitochondrial transcription machinery to human disease. Trends Genet. 2004, 20:513-519.
70. Lightowlers R.N., Chrzanowska-Lightowlers Z.M. PPR (pentatricopeptide repeat) proteins in mammals: important aids to mitochondrial gene expression. Biochem. J. 2008, 416:e5-e6.
71. Small I.D., Peeters N. The PPR motif - a TPR-related motif prevalent in plant organellar proteins. Trends Biochem. Sci. 2000, 25:46-47.
72. Steitz T.A. DNA-dependent and RNA-dependent DNA-polymerases. Curr. Opin. Struct. Biol. 1993, 3:31-38.
73. Florian J., Goodman M.F., Warshel A. Computer simulation of the chemical catalysis of DNA polymerases: discriminating between alternative nucleotide insertion mechanisms for T7 DNA polymerase. J. Am. Chem. Soc. 2003, 125:8163-8177.
74. Castro C., Arnold J.J., Cameron C.E. Incorporation fidelity of the viral RNA-dependent RNA polymerase: a kinetic, thermodynamic and structural perspective. Virus Res. 2005, 107:141-149.
75. Johnson K.A. Conformational coupling in DNA polymerase fidelity. Annu. Rev. Biochem. 1993, 62:685-713.
76. Johnson K.A. The kinetic and chemical mechanism of high-fidelity DNA polymerases. Biochim. Biophys. Acta 2010, 1804:1041-1048.
77. Joyce C.M., Benkovic S.J. DNA polymerase fidelity: kinetics, structure, and checkpoints. Biochemistry 2004, 43:14317-14324.
78. Ng K.K., Arnold J.J., Cameron C.E. Structure-function relationships among RNA-dependent RNA polymerases. Curr. Top. Microbiol. Immunol. 2008, 320:137-156.
79. Showalter A.K., Tsai M.D. A reexamination of the nucleotide incorporation fidelity of DNA polymerases. Biochemistry 2002, 41:10571-10576.
80. Gohara D.W., Arnold J.J., Cameron C.E. Poliovirus RNA-dependent RNA polymerase (3Dpol): kinetic, thermodynamic, and structural analysis of ribonucleotide selection. Biochemistry 2004, 43:5149-5158.
81. Smidansky E.D., Arnold J.J., Reynolds S.L., Cameron C.E. Human mitochondrial RNA polymerase: evaluation of the single-nucleotide-addition cycle on synthetic RNA/DNA scaffolds. Biochemistry 2011, 50:5016-5032.
82. Temiakov D., Anikin M., McAllister W.T. Characterization of T7 RNA polymerase transcription complexes assembled on nucleic acid scaffolds. J. Biol. Chem. 2002, 277:47035-47043.
83. Castro C., Smidansky E., Maksimchuk K.R., Arnold J.J., Korneeva V.S., Gotte M., Konigsberg W., Cameron C.E. Two proton transfers in the transition state for nucleotidyl transfer catalyzed by RNA- and DNA-dependent RNA and DNA polymerases. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:4267-4272.
84. Tang G.Q., Anand V.S., Patel S.S. Fluorescence-based assay to measure the real-time kinetics of nucleotide incorporation during transcription elongation. J. Mol. Biol. 2010, 405:666-678.
85. 2+. Biochemistry 2004, 43:5126-5137.
86. Huang Y., Eckstein F., Padilla R., Sousa R. Mechanism of ribose 2'-group discrimination by an RNA polymerase. Biochemistry 1997, 36:8231-8242.
87. Sydow J.F., Cramer P. RNA polymerase fidelity and transcriptional proofreading. Curr. Opin. Struct. Biol. 2009, 19:732-739.
88. Yuzenkova Y., Bochkareva A., Tadigotla V.R., Roghanian M., Zorov S., Severinov K., Zenkin N. Stepwise mechanism for transcription fidelity. BMC Biol. 2010, 8:54.
89. Deschauer M., Kiefer R., Blakely E.L., He L., Zierz S., Turnbull D.M., Taylor R.W. A novel Twinkle gene mutation in autosomal dominant progressive external ophthalmoplegia. Neuromuscul. Disord. 2003, 13:568-572.
90. Jacobs H.T., Turnbull D.M. Nuclear genes and mitochondrial translation: a new class of genetic disease. Trends Genet. 2005, 21:312-314.
91. Longley M.J., Graziewicz M.A., Bienstock R.J., Copeland W.C. Consequences of mutations in human DNA polymerase gamma. Gene 2005, 354:125-131.
92. Mootha V.K., Lepage P., Miller K., Bunkenborg J., Reich M., Hjerrild M., Delmonte T., Villeneuve A., Sladek R., Xu F., Mitchell G.A., Morin C., Mann M., Hudson T.J., Robinson B., Rioux J.D., Lander E.S. Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:605-610.
93. Wanrooij S., Falkenberg M. The human mitochondrial replication fork in health and disease. Biochim. Biophys. Acta 2010, 1797:1378-1388.
94. Wallace K.B. Mitochondrial off targets of drug therapy. Trends Pharmacol. Sci. 2008, 29:361-366.
95. Bonawitz N.D., Clayton D.A., Shadel G.S. Initiation and beyond: multiple functions of the human mitochondrial transcription machinery. Mol. Cell 2006, 24:813-825.
96. Cline S.D., Lodeiro M.F., Marnett L.J., Cameron C.E., Arnold J.J. Arrest of human mitochondrial RNA polymerase transcription by the biological aldehyde adduct of DNA, M1dG. Nucleic Acids Res. 2010, 38:7546-7557.
97. Niklison-Chirou M.V., Dupuy F., Saavedra L., Hebert E., Banchio C., Minahk C., Morero R.D. Microcin J25-Ga induces apoptosis in mammalian cells by inhibiting mitochondrial RNA-polymerase. Peptides 2011, 32:832-834.
98. Arnold J.J., Smidansky E.D., Reynolds S., Cameron C.E. The human mitochondrial RNA polymerase as an off target for antiviral ribonucleosides. Mitochondrion 2010, 10:206.
99. Bailey C.M., Anderson K.S. A mechanistic view of human mitochondrial DNA polymerase gamma: providing insight into drug toxicity and mitochondrial disease. Biochim. Biophys. Acta 2010, 1804:1213-1222.
100. Lee H., Hanes J., Johnson K.A. Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase. Biochemistry 2003, 42:14711-14719.
101. Lewis W., Day B.J., Copeland W.C. Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat. Rev. Drug Discov. 2003, 2:812-822.
102. Anderson K.S. A transient kinetic approach to investigate nucleoside inhibitors of mitochondrial DNA polymerase gamma. Methods 2010, 51:392-398.
103. Brown N.A. Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: nucleoside analogues. Expert Opin. Investig. Drugs 2009, 18:709-725.
104. Carroll S.S., Ludmerer S., Handt L., Koeplinger K., Zhang N.R., Graham D., Davies M.E., MacCoss M., Hazuda D., Olsen D.B. Robust antiviral efficacy upon administration of a nucleoside analog to hepatitis C virus-infected chimpanzees. Antimicrob. Agents Chemother. 2009, 53:926-934.
105. Klumpp K., Leveque V., Le Pogam S., Ma H., Jiang W.R., Kang H., Granycome C., Singer M., Laxton C., Hang J.Q., Sarma K., Smith D.B., Heindl D., Hobbs C.J., Merrett J.H., Symons J., Cammack N., Martin J.A., Devos R., Najera I. The novel nucleoside analog R1479 (4'-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture. J. Biol. Chem. 2006, 281:3793-3799.
106. Lange C.M., Sarrazin C., Zeuzem S. Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapy. Aliment. Pharmacol. Ther. 2010, 32:14-28.
107. Tomassini J.E., Getty K., Stahlhut M.W., Shim S., Bhat B., Eldrup A.B., Prakash T.P., Carroll S.S., Flores O., MacCoss M., McMasters D.R., Migliaccio G., Olsen D.B. Inhibitory effect of 2'-substituted nucleosides on hepatitis C virus replication correlates with metabolic properties in replicon cells. Antimicrob. Agents Chemother. 2005, 49:2050-2058.
108. Sarrazin C., Hezode C., Zeuzem S., Pawlotsky J.M. Antiviral strategies in hepatitis C virus infection. J. Hepatol. 2012, 56(Suppl. 1):S88-S100.
109. Vermehren J., Sarrazin C. New HCV therapies on the horizon. Clin. Microbiol. Infect. 2011, 17:122-134.
110. Dolce V., Fiermonte G., Runswick M.J., Palmieri F., Walker J.E. The human mitochondrial deoxynucleotide carrier and its role in the toxicity of nucleoside antivirals. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:2284-2288.
111. Lai Y., Tse C.M., Unadkat J.D. Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs. J. Biol. Chem. 2004, 279:4490-4497.
112. Leung G.P., Tse C.M. The role of mitochondrial and plasma membrane nucleoside transporters in drug toxicity. Expert Opin. Drug Metab. Toxicol. 2007, 3:705-718.
113. Scatena R., Bottoni P., Botta G., Martorana G.E., Giardina B. The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. Am. J. Physiol. Cell Physiol. 2007, 293:C12-C21.
114. Wheeler L.J., Mathews C.K. Nucleoside triphosphate pool asymmetry in mammalian mitochondria. J. Biol. Chem. 2011, 286:16992-16996.